ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Cardinal Health Recalls 9 Million Surgical Gowns for Possible Contamination


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Surgical Gowns in Operating Room at Hospital

When Cardinal Health recalled 9.1 million surgical gowns in January, it set off a ripple effect as hospitals and surgical centers braced for potential shortages. Cardinal warned that the gowns were potentially contaminated, increasing the risk of spreading infections to patients during surgery.

“An improperly sterilized surgical gown could compromise a sterile field and increase the risk of a surgical site infection,” Cardinal Health said in its Urgent Medical Device Recall.

The gowns had been manufactured in China. A week after the U.S. Food and Drug Administration announced the recall; Cardinal announced that its Chinese gown manufacturer had been using an outside contractor not registered with the FDA.

The unregistered subcontractor’s factory left windows open, lacked proper hand-washing stations, had an unsecured door and food was found in the manufacturing area, according to a report in Modern Healthcare.

The recall affected Level 3 surgical gowns, which provide moderate to high protection during surgeries, according to the FDA. Level 3 gowns are designed to protect both the patient and surgical team members from the transfer of bodily fluids, microorganisms and harmful particles.

Gown brands affected by the recall:

  • Cardinal Non-Reinforced Surgical Gowns
  • Cardinal Fabric-Reinforced Surgical Gowns
  • RoyalSilk Non-Reinforced Surgical Gowns

The gowns were manufactured between Sept. 1, 2018 and Jan. 10, 2020 and came packaged in Cardinal Health’s PreSource Kits. These are packages that contain several items pre-packaged together for specific surgeries. Other items in the packs were separately sealed and believed to be free from potential contamination, according to Cardinal Health.

The FDA recommended that hospitals and surgical centers discontinue use of all gowns immediately because their sterility could not be assured. 

Gowns May Have Put Patients at Risk While Delaying Surgeries

The recall affected 2,897 hospitals, surgery centers and other facilities around the world, including many in the United States. The recall created a sudden shortage that left some health care providers scrambling. One hospital chain alone reported canceling about 200 elective surgeries.  

“We also understand this issue may already be impacting patient care at health care facilities, such as the cancellation of non-elective surgeries,” an FDA statement read at the time.

Because the affected gowns were manufactured since the fall of 2018, it is likely some of the gowns had already been used in surgeries. The gowns are often worn in deep tissue surgery such as knee replacements or open heart surgery which carry a heightened risk of infection.

The affected surgical gowns are considered medical devices. Past infections traced to medical devices have resulted in medical device lawsuits against manufacturers.

The FDA and Cardinal Health said at the time of the recall that neither was aware of any patients being infected due to the gowns. But the FDA maintains a website where patients can report medical device injuries. People who believe patient infections may be linked to the gowns can report injuries to the FDA’s MedWatch program. 

Recall Came as U.S. COVID-19 Response Ramped Up

The Cardinal Health medical gown recall came just as the earliest cases of the novel coronavirus, COVID-19, were spreading out of China.

China has become a major manufacturing center for the drug and medical device supply chain in the United States and other countries around the world. The recall highlighted how precarious that supply chain is becoming.

“There are very real consequences that medical device supply chain disruptions can have on patients,” the FDA said in a statement announcing the Cardinal Health gown recall.

Hospitals have been moving to a so-called “just-in-time” supply chain to control costs. These are systems that deliver needed medical supplies or devices when the hospital needs them, reducing the costs of keeping an inventory in hospital supply rooms.

Cardinal Health was one of the medical device manufacturers exploring this business model as far back as 2015.

The business model has been highlighted with potential supply chain disruptions caused by the COVID-19 pandemic disrupting medical supplies from China.

The FDA reported the first drug shortage due to COVID-19 disruptions on February 28, but declined to identify the specific generic drug. FDA Commissioner Stephen Hahn said at the time that his agency had identified 63 manufacturers with a total of 72 facilities that manufacture essential medical devices and was in contact with all of them.

“Essential devices are those that may be prone to potential shortage if there is a supply disruption,” Hahn said in a statement. 

On March 11, the FDA issued a letter to health care providers on surgical mask and gown conservation strategies, saying it recognized that the need for surgical gowns, masks and other personal protective gear may outpace the supply during the COVID-19 pandemic in the United States.

Among the FDA’s recommendations was the idea to reuse single-use gowns for multiple patients under certain conditions and to continue using surgical masks beyond their manufacturers’ recommended expiration date.

Terry Turner
Written By Terry Turner Writer

Terry Turner has been writing articles and producing news broadcasts for more than 25 years. He covers FDA policy, proton pump inhibitors, and medical devices such as hernia mesh, IVC filters, and hip and knee implants. An Emmy-winning journalist, he has reported on health and medical policy issues before Congress, the FDA and other federal agencies. Some of his qualifications include:

  • American Medical Writers Association (AMWA) and The Alliance of Professional Health Advocates member
  • Centers for Disease Control and Prevention Health Literacy certificates
  • Original works published or cited in Washington Examiner, MedPage Today and The New York Times
  • Appeared as an expert panelist on hernia mesh lawsuits on the BBC
Edited By

13 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Abbott, E. (2020, February 28). First Coronavirus-Related Drug Shortage Hits the US. The Hill. Retrieved from
  2. American Hospital Association. (2020, January 23). Cardinal Health Launches Webpage for Gown Recall Updates. Retrieved from
  3. American Hospital Association. (2020, January 21). Quality Advisory: Cardinal Health Recalls Certain Surgical Gowns. Retrieved from
  4. Cardinal Health. (2020, January 30). Cardinal Health Announces Voluntary Field Actions for Select Procedure Packs Containing Affected Surgical Gowns. Retrieved from
  5. Cardinal Health. (2020, January 21). Urgent Medical Device Recall; Event #: 2020-02735. Retrieved from
  6. Green, C. (2015, May 6). Hospitals Turn to Just-in-Time Buying to Control Supply Chain Costs. Healthcare Finance. Retrieved from
  7. Kacik, A. (2020, January 24). Gown Recall Entangles Healthcare Supply Chain. Modern Healthcare. Retrieved from
  8. Lapook, J. (2020, January 31). Surgical Gown Recall Leaves Medical Centers Scrambling. CBS News. Retrieved from
  9. U.S. Food and Drug Administration. (2020, March 11). FAQs on Shortages of Surgical Masks and Gowns. Retrieved from
  10. U.S. Food and Drug Administration. (2020, January 16). Surgical Gowns and Packs by Cardinal Health: FDA Statement - Potential Quality Issues Affecting Some of Its Level 3 Surgical Gowns and Accompanying PreSource Procedural Packs. Retrieved from
  11. U.S. Food and Drug Administration. (2020, March 11). Statement on Quality Issues with Certain Cardinal Health Surgical Gowns and Packs. Retrieved from
  12. U.S. Food and Drug Administration. (2020, March 16). MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Retrieved from
  13. U.S. Food and Drug Administration. (2020, March 11). Surgical Mask and Gown Conservation Strategies – Letter to Healthcare Providers. Retrieved from
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(888) 645-1617